Skip to main content
. 2017 Mar 9;8(20):33002–33013. doi: 10.18632/oncotarget.16031

Figure 2.

Figure 2

(A) shows the relationship between total tumour cell p-p65 expression and cancer-specific survival in patients with primary operable invasive ductal breast cancer (P=0.025). (B) shows the relationship between total tumour cell p-p65 expression and cancer-specific survival in patients with Luminal A invasive ductal breast cancer (P=0.712). (C) shows the relationship between total tumour cell p-p65 expression and cancer-specific survival in patients with Luminal B invasive ductal breast cancer (P=0.142). (D) shows the relationship between total tumour cell p-p65 expression and cancer-specific survival in patients with Triple negative invasive ductal breast cancer (P=0.109). (E) shows the relationship between total tumour cell p-p65 expression and cancer-specific survival in patients with HER2 enriched invasive ductal breast cancer (P=0.992).